COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells. - Wikidata - awgldk - TriplyDB

COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells.

COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells.

http://www.wikidata.org/entity/Q37385171

about

Estrogen as Jekyll and Hyde: regulation of cell death Loss of the N-terminal methyltransferase NRMT1 increases sensitivity to DNA damage and promotes mammary oncogenesis WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines.High NR2F2 transcript level is associated with increased survival and its expression inhibits TGF-β-dependent epithelial-mesenchymal transition in breast cancer.Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer.Genome-wide miRNA response to anacardic acid in breast cancer cells.Transcriptomic response of breast cancer cells to anacardic acid.

P2860

Q34570235-3BA7BCD1-2314-4926-9BA7-4D02A5142F2E Q35828551-3F6FDACF-288A-4E6A-8F83-81F0D5ABAAE8 Q37267630-9EDBE15C-E131-43CD-B0DE-028B4FE7AEF3 Q38965383-2102275C-8D95-4328-A2EC-6C18915A13E1 Q39434758-3B4F56C7-D6B6-4228-82F1-FD7D8178B11A Q41491494-8C9374BF-26C2-4FA5-847C-5368E8B0189D Q55061507-C7B381C4-0D67-44A4-BBC7-87A285CB561E

P2860

COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells.

http://www.wikidata.org/entity/Q37385171

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells.

@en

COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells.

@nl

type

label

COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells.

@en

COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells.

@nl

prefLabel

COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells.

@en

COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells.

@nl

P1433

Q37385171-3456D4E1-C1D2-43B9-ABB7-5D506FEB9B69

P1476

Q37385171-7F6C5F1D-DD58-4EF6-BF43-2A1887A983FD

P2093

Q37385171-2D8E5DE6-3D54-4534-B80A-4367659FC3B6

Q37385171-57B1C2B5-74B8-4AC5-A3CA-15B3835E95DF

Q37385171-92AA11E8-3D3F-4FE4-B609-FA24FD86B192

P2860

Q37385171-10846717-91D8-4AFB-8967-BBE810591D4C

Q37385171-20FECEEB-D5EC-4C37-B737-939B525DA8EB

Q37385171-21266320-3355-42F5-BE77-BC98BFF8B6B1

Q37385171-23144185-36F0-41B3-9E6D-A7852F94E853

Q37385171-244DAB80-CABC-4771-9863-EA7C602D8304

Q37385171-253E0CE4-6307-4D5B-8294-B210F97BC227

Q37385171-27B58DE8-B1EB-4D64-B7A3-5C2AD817C829

Q37385171-2DC78ED4-0AFB-4420-B4FA-DE3BA7EFAE7C

Q37385171-2E9FB8A8-2D13-4D9F-AF24-7666BAD94148

Q37385171-2EB983EA-5B90-450E-B6D4-68DF24CF719A

P304

Q37385171-00E397FB-1FFD-498D-8F17-3D997BE8786F

P31

Q37385171-DFFF3D40-8BD5-498E-A9A6-3095A1CB0C97

P356

Q37385171-A44DB722-F829-47E6-B138-28B306DA5630

P433

Q37385171-E992E710-749E-40C5-B05D-ED3B83F5DAD4

P478

Q37385171-5A884C27-BB9F-434A-8A8F-99037719C349

P50

Q37385171-0D69870A-5354-44EC-9CB2-542BF2ABB99E

P577

Q37385171-323FE9B6-4FF4-4820-8386-46DA1A6255BA

P698

Q37385171-A26CFEC8-F2A7-41DD-9C61-DD10949A79C5

P932

Q37385171-9258C82B-7013-4AA0-B568-945521804B9A

P356

J.MCE.2013.10.010

P1433

Molecular and Cellular Endocrinology

P1476

COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells.

@en

P2093

Lacey M Litchfield

http://www.w3.org/2001/XMLSchema#string

Savitri N Appana

http://www.w3.org/2001/XMLSchema#string

Susmita Datta

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of nucleolin as a COUP-TFII coactivator of retinoic acid receptor β transcription in breast cancer cells

A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex

Isolation, characterization, and chromosomal localization of mouse and human COUP-TF I and II genes

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.

CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression

Integrating cell-signalling pathways with NF-kappaB and IKK function

Comparative analyses of mechanistic differences among antiestrogens

Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

P304

358-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MCE.2013.10.010

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

382

http://www.w3.org/2001/XMLSchema#string

P50

Carolyn M. Klinge

P577

2013-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24141032

http://www.w3.org/2001/XMLSchema#string

P932

5089806

http://www.w3.org/2001/XMLSchema#string